CAUDILL CORTNEY (SVP, CHIEF OPERATING OFFICER) sold 80.4% of their position (28.86K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.96M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$33.51
Trade value
$670.20K
% of position
Common Stock
Shares
−17.90K
Price / share
$67.75
Trade value
$1.21M
% of position
Common Stock
Shares
−2.10K
Price / share
$68.25
Trade value
$143.33K
% of position
Common Stock
Shares
+1.55K
Price / share
$33.51
Trade value
$51.81K
% of position
Common Stock
Shares
−8.86K
Price / share
$67.64
Trade value
$599.09K
% of position
Net shares
−7.31K
Net value
-$1.23M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | M · Option Exercise | +20K | $33.51 | $670.20K | 139.2% | 14.37K | 34.37K |
| Common Stock Direct | 3/9/2026 | S · Sale | −17.90K | $67.75 | $1.21M | 52.1% | 34.37K | 16.47K |
| Common Stock Direct | 3/9/2026 | S · Sale | −2.10K | $68.25 | $143.33K | 12.8% | 16.47K | 14.37K |
| Common Stock Direct | 3/10/2026 | M · Option Exercise | +1.55K | $33.51 | $51.81K | 10.8% | 14.37K | 15.91K |
| Common Stock Direct | 3/10/2026 | S · Sale | −8.86K | $67.64 | $599.09K | 55.7% | 15.91K | 7.05K |
| Total | −7.31K | -$1.23M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
33.51
Held after
69.22K
Exercisable
—
Option to Purchase Common Stock
Common Stock
1.55K shares
Shares
−1.55K
Strike price
33.51
Held after
67.68K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 3/9/2026 | M · Option Exercise | −20K | 33.51 | — | 69.22K |
| Option to Purchase Common Stock Direct | Common Stock1.55K shares | 3/10/2026 | M · Option Exercise | −1.55K | 33.51 | — | 67.68K |